ACCURACY OF AN AI-BASED SYMPTOM CHECKER AND AN ONLINE SELF-REFERRAL TOOL IN RHEUMATOLOGY: RESULTS FROM A MULTICENTER RANDOMIZED CONTROLLED TRIAL

被引:1
|
作者
Knitza, J. [1 ,2 ]
Tascilar, K.
Fuchs, F.
Mohn, J.
Simon, D.
Kleyer, A.
Bergmann, C.
Labinsky, H.
Morf, H.
Araujo, E.
Bohr, D.
Muehlensiepen, F. [3 ]
Englbrecht, M.
Vorbrueggen, W. [4 ]
Von der Decken, C. B. [5 ]
Kleinert, S. [6 ]
Ramming, A.
Distler, J.
Bartz-Bazzanella, P. [7 ]
Vuillerme, N. [8 ]
Schett, G.
Welcker, M. [9 ]
Hueber, A. [10 ]
机构
[1] Friedrich Alexander Univ Erlangen Nurnberg, Erlangen, Germany
[2] Univ Klinikum Erlangen, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany
[3] Fac Hlth Sci Brandenburg, Brandenburg Med Sch, Rudersdorf, Germany
[4] Verein Forderung Rheumatol eV, Wurselen, Germany
[5] Med Versorgungszentrum, Stolberg, Germany
[6] Rapp, Rheumatol Schwerpunktpraxis, Drs Kleinert, Ronneberger,Schuch u Wendler, Erlangen, Germany
[7] Rhein Maas Klinikum, Klin Internist Rheumatol, Wurselen, Germany
[8] Univ Grenoble Alpes, AGEIS, Grenoble, France
[9] Dr Martin Welcker GmbH, MVZ Rheumatol, Planegg, Germany
[10] Paracelsus Med Univ, Klinikum Nurnberg, Div Rheumatol, Nurnberg, Germany
关键词
D O I
10.1136/annrheumdis-2023-eular.1206
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS0377
引用
收藏
页码:442 / 442
页数:1
相关论文
共 50 条
  • [41] Improving Caregiver Self-Efficacy and Children's Behavioral Outcomes via a Brief Strength-Based Video Coaching Intervention: Results from a Randomized Controlled Trial
    Liu, Sihong
    Phu, Tiffany
    Dominguez, Amy
    Hurwich-Reiss, Eliana
    McGee, Drew
    Watamura, Sarah
    Fisher, Philip
    PREVENTION SCIENCE, 2021,
  • [42] Improved adherence to pegylated interferon alpha 2B+ribavirin in academic centers vs. community-based centers: Results from a prospective, randomized, controlled, multicenter trial.
    Flamm, SL
    Goldman, J
    Nelligan, G
    Cahan, J
    Chua, D
    Shapiro, B
    Yapp, R
    Jurkovic, E
    Sepe, T
    Brown, R
    HEPATOLOGY, 2003, 38 (04) : 299A - 299A
  • [43] Addressing post-COVID-19 musculoskeletal symptoms through pulmonary rehabilitation with an evidence-based eHealth education tool: Preliminary results from a pilot randomized controlled clinical trial
    Sanchez-Romero, Eleuterio A.
    Garcia-Barredo-Restegui, Teresa
    Martinez-Rolando, Lidia
    Villafane, Jorge Hugo
    Galan-Fraguas, Andrea
    Jurado-Molina, Rebeca
    Cuenca-Zaldivar, Juan Nicolas
    Soto-Goni, Xabier A.
    Martinez-Lozano, Pedro
    MEDICINE, 2025, 104 (10)
  • [44] Symptom management through electronic patient-reported outcome (ePRO)-based intervention in patients with breast cancer treated with abemaciclib: Primary results from the LIBRA study, a phase II randomized controlled trial
    Takano, Toshimi
    Hayashida, Tetsu
    Nagayama, Aiko
    Ozaki, Yukinori
    Takahashi, Maiko
    Seki, Tomoko
    Yokoe, Takamichi
    Aoyama, Yosuke
    Kizawa, Rika
    Nishimura, Meiko
    Hosonaga, Mari
    Hara, Fumikata
    Kobayashi, Takayuki
    Ueno, Takayuki
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] Effectiveness of a Virtual-Reality-Based Self-Help Intervention for Lowering the Psychological Burden during the COVID-19 Pandemic: Results from a Randomized Controlled Trial in Iran
    Farahimanesh, Sharareh
    Serino, Silvia
    Tuena, Cosimo
    Di Lernia, Daniele
    Wiederhold, Brenda K.
    Bernardelli, Luca
    Riva, Giuseppe
    Moradi, Alireza
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [46] Effects of exercise referral schemes enhanced with behavioural self-management strategies on functional capacity and self-reported disability in community-dwelling older adults. Secondary results from the SITLESS multi-country, three-armed randomized controlled trial
    Olsen, Pia O.
    Tully, Mark A.
    Del Pozo Cruz, Borja
    Gine-Garriga, Maria
    Coll-Planas, Laura
    Roque, Marta
    Rothenbacher, Dietrich
    Dallmeier, Dhayana
    Sansano-Nadal, Oriol
    Blackburn, Nicole E.
    Wilson, Jason J.
    Skjodt, Mathias
    Caserotti, Paolo
    AGE AND AGEING, 2024, 53 (10)
  • [47] Ibgard®, a Novel Targeted Delivery System of Peppermint Oil, Results in Significant Improvement in the Total IBS Symptom Score and Individual IBS Symptoms. Results From the US Based, 4-Week, Randomized, Placebo Controlled, Multi-Centered Ibsrest™ Trial
    Cash, Brooks D.
    Epstein, Michael S.
    Shah, Syed M.
    GASTROENTEROLOGY, 2015, 148 (04) : S662 - S663
  • [48] Ibgard®, a Novel Small Intestine Targeted Delivery System of Peppermint Oil, Results in Significant Improvement in Severe and Unbearable IBS Symptom Intensity. Results From a US Based, 4-Week, Randomized, Placebo-Controlled, Multi-Center Ibsrest™ Trial
    Cash, Brooks D.
    Epstein, Michael S.
    Shah, Syed M.
    GASTROENTEROLOGY, 2015, 148 (04) : S489 - S489
  • [49] From the identification of biopsychosocial risk factors to an increase in pain-related self-efficacy (IDRIS)-The online-based conveyance of an explanatory model for chronic back pain: Study protocol of a cohort multiple randomized controlled trial
    Engelmann, Petra
    Loewe, Bernd
    Huesing, Paul
    INTERNET INTERVENTIONS-THE APPLICATION OF INFORMATION TECHNOLOGY IN MENTAL AND BEHAVIOURAL HEALTH, 2022, 30
  • [50] DENIFANSTAT SIGNIFICANTLY IMPROVES LIVER FIBROSIS IN DIFFICULT-TO-TREAT METABOLIC DYSFUNCTIONASSOCIATED STEATOHEPATITIS (MASH) PATIENTS. RESULTS: FROM CONVENTIONAL AND AI-BASED PATHOLOGY FROM THE PHASE 2B FASCINATE-2, A 52-WEEK RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL OF FATTY ACID SYNTHASE (FASN) INHIBITOR DENIFANSTAT, IN F2/F3 MASH
    Loomba, Rohit
    Martins, Eduardo
    Grimmer, Katharine
    Tsai, Wen-Wei
    O'Farrell, Marie
    McCulloch, William
    Kemble, George
    Bedossa, Pierre
    Cobiella, Jose
    Lawitz, Eric
    Rudraraju, Madhavi
    Harrison, Stephen
    HEPATOLOGY, 2024, 80